Kineta, Inc. (KA) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Biotecnología industria. La empresa tiene su sede en Seattle, WA, United States. El CEO actual es Craig W. Philips.
KA tiene fecha de IPO 2016-02-11, 11 empleados a tiempo completo, cotiza en el NASDAQ Capital Marke, una capitalización de mercado de $7.05M.
Kineta, Inc., a clinical stage biotechnology company, develops immunotherapies for oncology, neuroscience, and biodefense. It serves private, government, and industry partners. The company has strategic partnerships with Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Kineta, Inc. was formerly known as Lecura, Inc. The company was incorporated in 2007 and is based in Seattle, Washington.
